Toxicity profile and pharmacokinetic study of a phase I low-dose schedule-dependent radiosensitizing paclitaxel chemoradiation regimen for inoperable non-small-cell lung cancer.
about
South Asian Medicinal Compounds as Modulators of Resistance to Chemotherapy and RadiotherapyRationally designed treatment for solid tumors with MAPK pathway activation: a phase I study of paclitaxel and bortezomib using an adaptive dose-finding approach.Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature Review.
P2860
Toxicity profile and pharmacokinetic study of a phase I low-dose schedule-dependent radiosensitizing paclitaxel chemoradiation regimen for inoperable non-small-cell lung cancer.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Toxicity profile and pharmacok ...... le non-small-cell lung cancer.
@ast
Toxicity profile and pharmacok ...... le non-small-cell lung cancer.
@en
type
label
Toxicity profile and pharmacok ...... le non-small-cell lung cancer.
@ast
Toxicity profile and pharmacok ...... le non-small-cell lung cancer.
@en
prefLabel
Toxicity profile and pharmacok ...... le non-small-cell lung cancer.
@ast
Toxicity profile and pharmacok ...... le non-small-cell lung cancer.
@en
P2093
P2860
P1476
Toxicity profile and pharmacok ...... le non-small-cell lung cancer.
@en
P2093
David W Johnstone
Kishan J Pandya
Peter C Keng
Richard Feins
Therese Smudzin
Thomas Watson
Yuhchyau Chen
P2860
P304
P356
10.1016/J.IJROBP.2007.10.011
P407
P577
2007-12-31T00:00:00Z